Same And Silybin

Verify with FDA CVM →

41 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
41
Total Reports
10
Deaths Reported
2440.0%
Death Rate

Active Ingredients

Same And Silybin

Administration Routes

OralUnknown

Species Affected

Dog 40
Cat 1

Most Affected Breeds

Chihuahua 5
Terrier - Yorkshire 3
Maltese 3
Dog (unknown) 3
Terrier (unspecified) 3
Poodle - Standard 2
Crossbred Canine/dog 2
Dog (other) 2
Dachshund - Standard Long-haired 1
Pug 1

Most Reported Reactions

Weight loss 11
Elevated serum alkaline phosphatase (SAP) 10
Elevated alanine aminotransferase (ALT) 9
Diarrhoea 9
Abnormal adrenocorticotropic hormone (ACTH) stimulation test 8
Lack of efficacy - NOS 8
INEFFECTIVE, CUSHINGS 7
Elevated gamma-glutamyl transferase (GGT) 6
Death by euthanasia 6
Proteinuria 6
Decreased appetite 6
Abnormal ultrasound finding 6

Outcome Breakdown

Outcome Unknown
20 (48.8%)
Ongoing
7 (17.1%)
Euthanized
7 (17.1%)
Recovered/Normal
4 (9.8%)
Died
3 (7.3%)

Data Summary

Metric Value
Total adverse event reports 41
Reports involving death 10
Case-fatality rate (reported events) 2440.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Same And Silybin Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 41 adverse event reports referencing Same And Silybin, including 10 reports in which the animal died — a 2440.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Same And Silybin. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Same And Silybin reports are Dog (40 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Chihuahua (5), Terrier - Yorkshire (3), Maltese (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Same And Silybin are Weight loss (11), Elevated serum alkaline phosphatase (SAP) (10), Elevated alanine aminotransferase (ALT) (9), Diarrhoea (9). Of the 41 reports with a coded outcome, Outcome Unknown is the leading category at 48.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Same And Silybin.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial